MoneyWorks4Me

The Sales for the quarter ended June 2025 of Rs. 121.01 millions rose by 48.35% from Rs. 81.57 millions.Net profit for the quarter ended June 2025 increased significantly by 50.60% to Rs. 6.31 millions from Rs. 4.19 millions.The company reported a good operating profit of 12.70 millions compared to 9.02 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 121.01 81.57 48.35 121.01 81.57 48.35 449.23 272.97 64.57
Other Income 0.12 0.12 0.00 0.12 0.12 0.00 0.78 0.06 1200.00
PBIDT 12.70 9.02 40.80 12.70 9.02 40.80 52.22 44.79 16.59
Interest 1.64 0.79 107.59 1.64 0.79 107.59 6.24 2.07 201.45
PBDT 11.06 8.23 34.39 11.06 8.23 34.39 45.98 42.22 8.91
Depreciation 2.54 2.56 -0.78 2.54 2.56 -0.78 10.15 10.44 -2.78
PBT 8.52 5.67 50.26 8.52 5.67 50.26 35.83 31.78 12.74
TAX 2.21 1.48 49.32 2.21 1.48 49.32 6.79 14.41 -52.88
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.22 0.00
PAT 6.31 4.19 50.60 6.31 4.19 50.60 29.04 17.37 67.18
Equity 64.37 64.37 0.00 64.37 64.37 0.00 64.37 64.37 0.00
PBIDTM(%) 9.38 10.17 -7.74 10.50 11.06 -5.09 10.43 15.09 -30.88
Peers
Company Name CMP
Sun Pharma. Inds. 1842.90
Dr. Reddys Labs. 1223.60
Cipla 1385.65
Lupin 2068.50
Zydus Lifesciences 1217.50
View more..